1,204.65
Netflix Inc stock is traded at $1,204.65, with a volume of 3.08M.
It is down -0.13% in the last 24 hours and up +1.22% over the past month.
Netflix's relatively simple business model involves only one business, its streaming service. It has the biggest television entertainment subscriber base in both the United States and the collective international market, with more than 300 million subscribers globally. Netflix has exposure to nearly the entire global population outside of China. The firm has traditionally avoided a regular slate of live programming or sports content, instead focusing on on-demand access to episodic television, movies, and documentaries. The firm introduced ad-supported subscription plans in 2022, giving the firm exposure to the advertising market in addition to the subscription fees that have historically accounted for nearly all its revenue.
See More
Previous Close:
$1,206.21
Open:
$1208.88
24h Volume:
3.08M
Relative Volume:
0.98
Market Cap:
$511.89B
Revenue:
$41.46B
Net Income/Loss:
$10.25B
P/E Ratio:
51.33
EPS:
23.47
Net Cash Flow:
$8.50B
1W Performance:
-2.77%
1M Performance:
+1.22%
6M Performance:
+20.09%
1Y Performance:
+74.85%
Netflix Inc Stock (NFLX) Company Profile
Name
Netflix Inc
Sector
Industry
Phone
408-540-3700
Address
121 ALBRIGHT WAY, LOS GATOS
Compare NFLX with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
NFLX
Netflix Inc
|
1,204.65 | 529.07B | 41.46B | 10.25B | 8.50B | 23.47 |
![]()
DIS
Walt Disney Co
|
118.86 | 209.55B | 94.13B | 12.55B | 11.55B | 6.38 |
![]()
LYV
Live Nation Entertainment Inc
|
165.72 | 37.60B | 23.72B | 775.11M | 1.08B | 2.31 |
![]()
WBD
Warner Bros Discovery Inc
|
12.05 | 29.26B | 38.41B | 640.00M | 4.07B | 0.30 |
![]()
FWONK
Liberty Media Corp
|
102.94 | 25.21B | 3.51B | -102.00M | 737.00M | -0.42 |
Netflix Inc Stock (NFLX) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jul-10-25 | Reiterated | KeyBanc Capital Markets | Overweight |
Jul-07-25 | Downgrade | Seaport Research Partners | Buy → Neutral |
Jul-02-25 | Reiterated | Canaccord Genuity | Buy |
Jul-02-25 | Reiterated | Goldman | Neutral |
Jun-20-25 | Reiterated | Pivotal Research Group | Buy |
Jun-12-25 | Reiterated | Oppenheimer | Outperform |
Jun-03-25 | Reiterated | Jefferies | Buy |
May-30-25 | Reiterated | BofA Securities | Buy |
May-19-25 | Downgrade | JP Morgan | Overweight → Neutral |
Apr-21-25 | Reiterated | BMO Capital Markets | Outperform |
Apr-21-25 | Reiterated | Barclays | Equal Weight |
Apr-21-25 | Reiterated | Canaccord Genuity | Buy |
Apr-21-25 | Reiterated | Guggenheim | Buy |
Apr-21-25 | Reiterated | JP Morgan | Overweight |
Apr-21-25 | Reiterated | KeyBanc Capital Markets | Overweight |
Apr-21-25 | Reiterated | MoffettNathanson | Buy |
Apr-21-25 | Reiterated | Morgan Stanley | Overweight |
Apr-21-25 | Reiterated | Oppenheimer | Outperform |
Apr-21-25 | Reiterated | Piper Sandler | Overweight |
Apr-21-25 | Reiterated | Pivotal Research Group | Buy |
Apr-21-25 | Reiterated | Wells Fargo | Overweight |
Apr-17-25 | Resumed | Piper Sandler | Overweight |
Mar-27-25 | Initiated | FBN Securities | Outperform |
Mar-17-25 | Upgrade | MoffettNathanson | Neutral → Buy |
Jan-24-25 | Upgrade | Bernstein | Mkt Perform → Outperform |
Jan-23-25 | Upgrade | Wolfe Research | Peer Perform → Outperform |
Jan-22-25 | Upgrade | Barclays | Underweight → Equal Weight |
Jan-22-25 | Upgrade | Canaccord Genuity | Hold → Buy |
Jan-22-25 | Reiterated | Oppenheimer | Outperform |
Jan-22-25 | Reiterated | Pivotal Research Group | Buy |
Jan-22-25 | Upgrade | Rosenblatt | Neutral → Buy |
Jan-22-25 | Upgrade | The Benchmark Company | Sell → Hold |
Jan-16-25 | Upgrade | Seaport Research Partners | Neutral → Buy |
Jan-15-25 | Reiterated | BMO Capital Markets | Outperform |
Jan-15-25 | Reiterated | Oppenheimer | Outperform |
Jan-08-25 | Reiterated | Goldman | Neutral |
Jan-06-25 | Reiterated | Argus | Buy |
Jan-03-25 | Reiterated | The Benchmark Company | Sell |
Dec-19-24 | Reiterated | UBS | Buy |
Dec-16-24 | Downgrade | Loop Capital | Buy → Hold |
Dec-16-24 | Reiterated | Oppenheimer | Outperform |
Dec-11-24 | Reiterated | JP Morgan | Overweight |
Nov-20-24 | Reiterated | Pivotal Research Group | Buy |
Oct-18-24 | Reiterated | Needham | Buy |
Oct-18-24 | Reiterated | Oppenheimer | Outperform |
Oct-18-24 | Reiterated | Pivotal Research Group | Buy |
Oct-16-24 | Reiterated | Loop Capital | Buy |
Oct-11-24 | Reiterated | Guggenheim | Buy |
Oct-10-24 | Reiterated | Morgan Stanley | Overweight |
Oct-10-24 | Reiterated | Oppenheimer | Outperform |
Oct-07-24 | Downgrade | Barclays | Equal Weight → Underweight |
Oct-07-24 | Upgrade | Piper Sandler | Neutral → Overweight |
Oct-01-24 | Reiterated | KeyBanc Capital Markets | Overweight |
Sep-05-24 | Initiated | China Renaissance | Hold |
Aug-30-24 | Reiterated | Pivotal Research Group | Buy |
Jul-17-24 | Reiterated | Guggenheim | Buy |
Jul-16-24 | Reiterated | The Benchmark Company | Sell |
Jul-15-24 | Reiterated | BofA Securities | Buy |
Jul-12-24 | Reiterated | JP Morgan | Overweight |
Jul-10-24 | Reiterated | KeyBanc Capital Markets | Overweight |
Jul-09-24 | Reiterated | TD Cowen | Buy |
Jul-02-24 | Reiterated | Argus | Buy |
May-28-24 | Reiterated | Evercore ISI | Outperform |
Apr-19-24 | Downgrade | Canaccord Genuity | Buy → Hold |
Apr-19-24 | Upgrade | Needham | Hold → Buy |
Apr-19-24 | Reiterated | Pivotal Research Group | Buy |
Apr-15-24 | Reiterated | Deutsche Bank | Hold |
Apr-12-24 | Reiterated | Morgan Stanley | Overweight |
Apr-12-24 | Reiterated | Piper Sandler | Neutral |
Apr-05-24 | Reiterated | Pivotal Research Group | Buy |
Mar-25-24 | Reiterated | Citigroup | Neutral |
Mar-12-24 | Reiterated | Jefferies | Buy |
Mar-11-24 | Reiterated | Oppenheimer | Outperform |
Jan-30-24 | Downgrade | Seaport Research Partners | Buy → Neutral |
Jan-25-24 | Upgrade | DZ Bank | Hold → Buy |
Jan-24-24 | Reiterated | BMO Capital Markets | Outperform |
Jan-24-24 | Reiterated | BofA Securities | Buy |
Jan-24-24 | Reiterated | Canaccord Genuity | Buy |
Jan-24-24 | Reiterated | Evercore ISI | Outperform |
Jan-24-24 | Reiterated | Goldman | Neutral |
Jan-24-24 | Reiterated | Guggenheim | Buy |
Jan-24-24 | Reiterated | JP Morgan | Overweight |
Jan-24-24 | Reiterated | KeyBanc Capital Markets | Overweight |
Jan-24-24 | Upgrade | Macquarie | Neutral → Outperform |
Jan-24-24 | Reiterated | Morgan Stanley | Overweight |
Jan-24-24 | Reiterated | Oppenheimer | Outperform |
Jan-24-24 | Reiterated | Piper Sandler | Neutral |
Jan-24-24 | Reiterated | Pivotal Research Group | Buy |
Jan-24-24 | Reiterated | Redburn Atlantic | Buy |
Jan-24-24 | Reiterated | Robert W. Baird | Outperform |
Jan-24-24 | Reiterated | TD Cowen | Outperform |
Jan-24-24 | Reiterated | UBS | Buy |
Jan-24-24 | Reiterated | Wells Fargo | Overweight |
Sep-18-23 | Reiterated | Evercore ISI | Outperform |
Aug-25-23 | Upgrade | Loop Capital | Hold → Buy |
Jul-24-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
Jul-17-23 | Reiterated | Deutsche Bank | Buy |
Jul-13-23 | Reiterated | JP Morgan | Overweight |
Jul-12-23 | Reiterated | UBS | Buy |
Jul-05-23 | Upgrade | Goldman | Sell → Neutral |
Jun-29-23 | Reiterated | Citigroup | Buy |
Jun-28-23 | Reiterated | Oppenheimer | Outperform |
Jun-13-23 | Reiterated | BofA Securities | Buy |
Jun-13-23 | Reiterated | Guggenheim | Buy |
Apr-19-23 | Reiterated | Deutsche Bank | Buy |
Apr-19-23 | Reiterated | JP Morgan | Overweight |
Apr-19-23 | Reiterated | Jefferies | Buy |
Apr-19-23 | Reiterated | Piper Sandler | Neutral |
Apr-19-23 | Reiterated | Pivotal Research Group | Buy |
Apr-19-23 | Reiterated | Rosenblatt | Neutral |
Apr-19-23 | Upgrade | UBS | Neutral → Buy |
Apr-11-23 | Resumed | Robert W. Baird | Neutral |
Jan-23-23 | Reiterated | Argus | Buy |
Jan-20-23 | Reiterated | Canaccord Genuity | Buy |
Jan-20-23 | Reiterated | Deutsche Bank | Buy |
Jan-20-23 | Reiterated | Evercore ISI | Outperform |
Jan-20-23 | Reiterated | Goldman | Sell |
Jan-20-23 | Reiterated | Guggenheim | Buy |
Jan-20-23 | Reiterated | Jefferies | Buy |
Jan-20-23 | Reiterated | MoffettNathanson | Market Perform |
Jan-20-23 | Reiterated | Oppenheimer | Outperform |
Jan-20-23 | Reiterated | Piper Sandler | Neutral |
Jan-20-23 | Reiterated | Pivotal Research Group | Buy |
Jan-20-23 | Reiterated | Robert W. Baird | Neutral |
Jan-20-23 | Reiterated | The Benchmark Company | Sell |
Jan-20-23 | Reiterated | Wedbush | Outperform |
Jan-20-23 | Reiterated | Wolfe Research | Outperform |
Jan-12-23 | Upgrade | Jefferies | Hold → Buy |
Jan-04-23 | Initiated | New Street | Neutral |
Dec-29-22 | Upgrade | CFRA | Sell → Buy |
Dec-14-22 | Reiterated | Jefferies | Hold |
Dec-09-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
Jun-14-22 | Downgrade | The Benchmark Company | Hold → Sell |
Jun-10-22 | Downgrade | Goldman | Neutral → Sell |
May-16-22 | Upgrade | Wedbush | Neutral → Outperform |
Apr-21-22 | Downgrade | DZ Bank | Buy → Hold |
Apr-21-22 | Downgrade | Edward Jones | Buy → Hold |
Apr-20-22 | Downgrade | Atlantic Equities | Overweight → Neutral |
Apr-20-22 | Downgrade | BofA Securities | Buy → Underperform |
Apr-20-22 | Downgrade | JP Morgan | Overweight → Neutral |
Apr-20-22 | Upgrade | Needham | Underperform → Hold |
Apr-20-22 | Downgrade | Oppenheimer | Outperform → Perform |
Apr-20-22 | Downgrade | Piper Sandler | Overweight → Neutral |
Apr-20-22 | Downgrade | Pivotal Research Group | Buy → Sell |
Apr-20-22 | Downgrade | Stifel | Buy → Hold |
Apr-20-22 | Downgrade | UBS | Buy → Neutral |
Apr-20-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
Apr-19-22 | Initiated | Rosenblatt | Neutral |
Mar-09-22 | Upgrade | Wedbush | Underperform → Neutral |
Jan-31-22 | Upgrade | Citigroup | Neutral → Buy |
Jan-31-22 | Upgrade | Edward Jones | Hold → Buy |
Jan-24-22 | Downgrade | Jefferies | Buy → Hold |
Jan-21-22 | Reiterated | BMO Capital Markets | Outperform |
Jan-21-22 | Reiterated | BofA Securities | Buy |
Jan-21-22 | Reiterated | Canaccord Genuity | Buy |
Jan-21-22 | Reiterated | Cowen | Outperform |
Jan-21-22 | Reiterated | Deutsche Bank | Hold |
Jan-21-22 | Reiterated | Goldman | Neutral |
Jan-21-22 | Reiterated | Guggenheim | Buy |
Jan-21-22 | Reiterated | JP Morgan | Overweight |
Jan-21-22 | Reiterated | MoffettNathanson | Neutral |
Jan-21-22 | Downgrade | Monness Crespi & Hardt | Buy → Neutral |
Jan-21-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
Jan-21-22 | Reiterated | Oppenheimer | Outperform |
Jan-21-22 | Reiterated | Piper Sandler | Overweight |
Jan-21-22 | Reiterated | Pivotal Research Group | Buy |
Jan-21-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
Jan-21-22 | Reiterated | Stifel | Buy |
Jan-21-22 | Upgrade | The Benchmark Company | Sell → Hold |
Jan-21-22 | Downgrade | Truist | Buy → Hold |
Jan-21-22 | Reiterated | UBS | Buy |
Jan-21-22 | Reiterated | Wolfe Research | Outperform |
Dec-15-21 | Reiterated | The Benchmark Company | Sell |
Oct-20-21 | Downgrade | Deutsche Bank | Buy → Hold |
Oct-20-21 | Reiterated | Monness Crespi & Hardt | Buy |
Sep-29-21 | Reiterated | The Benchmark Company | Sell |
Sep-13-21 | Initiated | Goldman | Neutral |
Sep-08-21 | Reiterated | JP Morgan | Overweight |
Sep-07-21 | Reiterated | Atlantic Equities | Overweight |
Jul-21-21 | Reiterated | Credit Suisse | Outperform |
Jul-21-21 | Reiterated | Deutsche Bank | Buy |
Jul-21-21 | Reiterated | JP Morgan | Overweight |
Jul-21-21 | Reiterated | KeyBanc Capital Markets | Overweight |
Jul-21-21 | Reiterated | Stifel | Buy |
Jun-25-21 | Upgrade | Credit Suisse | Neutral → Outperform |
Jun-25-21 | Initiated | Edward Jones | Hold |
May-19-21 | Resumed | Jefferies | Buy |
Apr-21-21 | Resumed | Oppenheimer | Outperform |
Apr-21-21 | Reiterated | Pivotal Research Group | Buy |
Apr-21-21 | Upgrade | Stifel | Hold → Buy |
Apr-06-21 | Resumed | Evercore ISI | Outperform |
Apr-01-21 | Initiated | Piper Sandler | Overweight |
Mar-25-21 | Reiterated | The Benchmark Company | Sell |
Mar-23-21 | Upgrade | Argus | Hold → Buy |
Jan-21-21 | Upgrade | DZ Bank | Hold → Buy |
Jan-20-21 | Reiterated | Monness Crespi & Hardt | Buy |
Jan-20-21 | Reiterated | Pivotal Research Group | Buy |
Jan-20-21 | Reiterated | The Benchmark Company | Sell |
Jan-20-21 | Upgrade | UBS | Neutral → Buy |
Jan-20-21 | Upgrade | Wells Fargo | Equal Weight → Overweight |
Oct-21-20 | Reiterated | BMO Capital Markets | Outperform |
Oct-21-20 | Reiterated | Bernstein | Outperform |
Oct-21-20 | Reiterated | Jefferies | Buy |
Oct-21-20 | Reiterated | Morgan Stanley | Overweight |
Oct-21-20 | Reiterated | Oppenheimer | Outperform |
Oct-21-20 | Reiterated | Piper Sandler | Overweight |
Oct-21-20 | Reiterated | Pivotal Research Group | Buy |
Oct-21-20 | Reiterated | RBC Capital Mkts | Outperform |
Oct-21-20 | Reiterated | The Benchmark Company | Sell |
Oct-21-20 | Reiterated | Wedbush | Underperform |
Oct-21-20 | Reiterated | Wells Fargo | Equal Weight |
Oct-16-20 | Reiterated | Morgan Stanley | Overweight |
Oct-15-20 | Reiterated | Canaccord Genuity | Buy |
Oct-14-20 | Reiterated | Goldman | Buy |
Oct-07-20 | Reiterated | Pivotal Research Group | Buy |
Sep-28-20 | Reiterated | The Benchmark Company | Sell |
Sep-15-20 | Initiated | KeyBanc Capital Markets | Overweight |
Sep-09-20 | Resumed | Raymond James | Mkt Perform |
Sep-04-20 | Reiterated | The Benchmark Company | Sell |
Jul-29-20 | Reiterated | Loop Capital | Buy |
View All
Netflix Inc Stock (NFLX) Latest News
Roberts Capital Advisors LLC Purchases 1,253 Shares of Netflix, Inc. $NFLX - MarketBeat
Orphan Black: Acclaimed Sci-Fi Series Coming To Netflix US - IMDb
5,521 Shares in Netflix, Inc. $NFLX Bought by Bowie Capital Management LLC - MarketBeat
Netflix, Inc. $NFLX Stake Increased by Knuff & Co LLC - MarketBeat
YNET ETF's CAD 0.25 Dividend Signal Amid Netflix Stock Volatility - AInvest
'Fast & Furious': Which of the Movies Are Streaming on Netflix Now? - IMDb
Precision Trading with Netflix Inc. (NFLX) Risk Zones - news.stocktradersdaily.com
When Does ‘Interview With the Vampire’ Season 2 Come out on Netflix? - IMDb
The Reverse Netflix: 'KPop Demon Hunters' So Popular It Gets Theater Release After Streaming - inkl
Jacob Elordi Isn’t Grateful For Netflix Fame, He’s Dragging It for Frankenstein - IMDb
Netflix Streams Toward A Breakout — And Looks To Disrupt Disney. What Could Go Wrong? - Investor's Business Daily
‘Stranger Things’ Creators Leave Netflix For New Production Company - Men's Journal
Why We're Hopeful 'Love Is Blind: UK' Stars Kal and Sarover's Connection Lasts - marieclaire.com
Netflix’s $200 million Thailand play marks big Asia content push - The Mercury News
Emily in Paris Sets Season 5 Premiere Date at Netflix — Get a First Look - IMDb
Shah Rukh Khan Unveils Teaser for Son Aryan’s Netflix Debut ‘The Ba***ds of Bollywood’ - IMDb
Marvel Movie Surges On Netflix Charts 20 Years After Box Office Flop - IMDb
Gradle, Inc. Releases Develocity 360 to Boost Toolchain Observability for GenAI Software Delivery - GlobeNewswire Inc.
Banco Bilbao Vizcaya Argentaria S.A. Has $25.75 Million Stock Holdings in Netflix, Inc. $NFLX - MarketBeat
Bowen Hanes & Co. Inc. Sells 7,442 Shares of Netflix, Inc. $NFLX - MarketBeat
ZEGA Investments LLC Increases Stock Holdings in Netflix, Inc. $NFLX - MarketBeat
JT Stratford LLC Sells 1,976 Shares of Netflix, Inc. $NFLX - MarketBeat
Netflix, Inc. $NFLX Shares Acquired by Texas Capital Bank Wealth Management Services Inc - MarketBeat
MIG Capital LLC Acquires Shares of 732 Netflix, Inc. $NFLX - MarketBeat
Colonial Trust Advisors Acquires 1,496 Shares of Netflix, Inc. $NFLX - MarketBeat
Bank OZK Buys 602 Shares of Netflix, Inc. $NFLX - MarketBeat
RWA Wealth Partners LLC Sells 6,767 Shares of Netflix, Inc. $NFLX - MarketBeat
The Zacks Analyst Blog Highlights Netflix, Mastercard, Shell and Moving iMage - sg.finance.yahoo.com
The Zacks Analyst Blog Highlights Netflix and Disney - Yahoo Finance
‘MATCHROOM: THE GREATEST SHOWMEN’ – FIRST LOOK AT NEW NETFLIX DOCUMENTARY SERIES AS OFFICIAL LAUNCH DATE IS CONFIRMED - Matchroom Pool
Netflix’s $200 Million Thailand Play Marks Big Asia Content Push - Bloomberg.com
Streaming this week: Top Netflix, Prime Video, JioHotstar & Other picks you can’t miss - Deccan Herald
NETFLIX COM INC : Receives a Buy rating from Bernstein - MarketScreener
Netflix, Inc. $NFLX Shares Bought by Boston Family Office LLC - MarketBeat
Top Analyst Reports for Netflix, Mastercard & Shell - Nasdaq
Netflix and Adam McKay Win Dismissal of Second ‘Don’t Look Up’ Copyright Suit - IMDb
Is Netflix Stock A Buy After Ad Sales Success? - Investor's Business Daily
‘Wednesday’ Season 2 Gains 29.1 Million Views in Second Week on Netflix - IMDb
What's Going On With Netflix (NFLX) Stock Tuesday?Netflix (NASDAQ:NFLX) - Benzinga
Top 10 Movies and Shows on Netflix: Week of August 11, 2025 - IMDb
‘Stranger Things’ Creators Matt and Ross Duffer Sign Four-Year Paramount Deal, Set Netflix Exit in April 2026 - IMDb
Duffer Brothers Close 4-Year Film, TV & Streaming Megadeal With Paramount, Set Netflix Exit - Deadline
Unpacking Netflix’s Sudden Intraday Downturn: What’s Really Moving the Stock? - AInvest
Netflix Bollywood Dance Film ‘Best of the Best’ Rounds Out Ensemble Cast (Exclusive) - IMDb
Whip it good: Netflix documentary highlights 52-year career of Devo - Enterprise News
Mark Rober, kid-friendly engineer, to experiment with new Netflix show - USA Today
Stock Analysis | Netflix OutlookA Balanced Approach Amid Technical Neutrality - AInvest
“Succession Meets Peaky Blinders”: ‘House of Guinness’ Is Netflix’s New Drama Based on the Real Family - Cosmopolitan
Streaming Keeps Surging In July, With YouTube, Netflix And Roku Channel Hitting New Nielsen Highs - IMDb
Netflix, Inc. $NFLX Shares Acquired by BNP PARIBAS ASSET MANAGEMENT Holding S.A. - MarketBeat
Pinnacle Wealth Management LLC Sells 2,090 Shares of Netflix, Inc. $NFLX - MarketBeat
Netflix Inc Stock (NFLX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Netflix Inc Stock (NFLX) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
HYMAN DAVID A | Chief Legal Officer |
Aug 05 '25 |
Sale |
1,158.67 |
424 |
491,276 |
31,610 |
Neumann Spencer Adam | Chief Financial Officer |
Aug 06 '25 |
Sale |
1,161.21 |
685 |
795,432 |
3,691 |
Peters Gregory K | Co-CEO |
Aug 05 '25 |
Sale |
1,157.44 |
2,026 |
2,344,964 |
12,781 |
SARANDOS THEODORE A | Co-CEO |
Aug 05 '25 |
Sale |
1,160.62 |
2,026 |
2,351,411 |
15,168 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):